Cardinal Health Inc. said Thursday its profit fell 26 percent in the fiscal second quarter after it spun off its medical technology business, but the drug distributor boosted its full-year profit guidance, sending it shares to a new high.

Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration issued a complete response letter regarding the new drug application for Zuplenz oral soluble film for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery.

CVS Caremark Corp said recent problems at its pharmacy benefits management unit have been corrected and it posted a slightly better-than-expected rise in quarterly profit as its drugstore bested its rivals, driving the company's shares up as much as 8.8 percent.

Teva Pharmaceutical Industries Ltd. and Active Biotech amended their marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis.

Earnings rose to $1.05 billion, or 74 cents per share, in the fourth quarter from $949 million, or 65 cents per share, a year earlier.

Biotechnology company Amgen Inc. said Monday its profit rose 1 percent in the fourth quarter, as the company reported mixed results for its anemia drugs, but said sales of its other drugs held steady.

Defense contractor Northrop Grumman Corp. said Thursday it posted a fourth-quarter profit of $413 million in contrast to a year-ago loss as sales rose 2 percent.

Friday, February 5, 2010 at 7:46 a.m. WOONSOCKET, R.I. - Drugstore operator and pharmacy benefits manager CVS Caremark Corp.

Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, said Friday it is settling several lawsuits related to Medicaid reimbursement for its products, and is setting aside $315 million to cover the settlement and other suits.

Bangalore, Karnataka, India, Thursday, February 04, 2010 -- Biocon and Bayer Healthcare, a subsidiary of Bayer AG, one of the worldA's leading, innovative companies in the healthcare and medical products industry; have entered into a strategic partnership to fight the diabetes menace in India.

Achillion Pharmaceuticals Inc. said Tuesday that it has raised $22.9 million from its recent sale of additional shares of common stock.

Feb 2, 2010 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for filing Teva's Biologics License Application for XM02, a granulocyte colony-stimulating factor for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with ...

Tuesday, February 02, 2010 Panola County Arrest Log 02-02-10 The following information was taken from the log book at the David M. Bryan Justice Complex.

MORRISTOWN,A N.J. Watson Pharmaceuticals and HRA Pharma have signed a deal whereby Watson will become the commercial partner for an emergency contraceptive undergoing regulatory review by the Food and Drug Administration, Watson announced Monday.

Cardinal Health plans to close its Findlay, Ohio, distribution center in April, a move that will put about 115 employees out of work, the company said yesterday.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Bayer Schering Pharma AG, Germany has announced that an independent Data Safety and Monitoring Board has completed an interim analysis of a phase II trial of the company's long-acting recombinant factor VIII, BAY79-4980. The DSMB concluded that the study will not be able to achieve the predetermined efficacy endpoint .

Time Warner Cable Inc. reported a profit for the fourth quarter Thursday but the economy was still weighing on its customers, who cut back on their subscriptions of premium movie channels and ordered fewer videos on demand.

Molybdenum producer Thompson Creek Metals says its previously announced switch to U.S. accounting principles will require a different treatment for the warrants it has issued and that will result in a net loss for fiscal 2009.

The absence of Cardinal Health Inc. 's CareFusion Corp. spinoff drove the health-care giant's fiscal second-quarter earnings down, but the company is raising its full-year outlook after closing the books on the first half of the year.